Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer
British Journal of Cancer 117, e1 (22 August 2017). doi:10.1038/bjc.2017.80
Authors: A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip J Coates, Michael McMahon, Frank A Carey, Tadashi Honda, John D Hayes, Colin J Henderson & C Roland Wolf
http://ift.tt/2o2pH3t
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου